This test is most useful if any of these apply to you.
Your cells run on a tiny chemical assembly line that turns food into energy. When that assembly line stalls, one of the intermediate molecules, succinate, can pile up and spill into your urine. Measuring it offers a window into how well your cellular energy machinery is working, which is information no standard metabolic panel captures.
This is a research-grade marker without standardized clinical cutpoints, so a single number is less useful than tracking your own trend over time. Used that way, urinary succinate can flag early shifts in kidney metabolism, mitochondrial stress, and gut microbiome activity that other labs miss.
Succinate (sometimes called succinic acid) is a normal step in your cells' main energy-producing pathway, called the TCA cycle or Krebs cycle. Think of the TCA cycle as a chemical loop that takes the food you eat and converts it into the energy your cells use to function. Succinate is one of the links in that chain.
You make succinate in nearly every cell type, and your gut bacteria also produce it. Normally, an enzyme called succinate dehydrogenase keeps the cycle moving by converting succinate into the next molecule. When the cycle slows down or your cells are under stress, succinate accumulates and some of it ends up in your urine. This test reports how much you are excreting.
Because succinate sits at the crossroads of energy production, inflammation signaling, and gut microbiome activity, an unusual reading can reflect several different processes. It does not point to one specific disease on its own, which is why it is most useful when interpreted alongside other markers and tracked over time.
Among the conditions most consistently linked to urinary succinate, kidney disease stands out. The pattern is not simple: succinate can move in opposite directions depending on the type of kidney disease, which makes context essential.
In people with type 2 diabetes, higher urinary succinate has been independently associated with diabetic kidney disease, more protein leaking into the urine, and a faster decline in kidney filtration over time. The link held up after adjustment for traditional risk factors, supporting succinate as a candidate early marker of diabetic kidney damage.
In people with non-diabetic chronic kidney disease, the picture flips. Urinary succinate and other TCA cycle metabolites were reduced compared with healthy controls. The lower numbers reflect that the diseased kidney is no longer producing or processing these molecules normally, a pattern researchers interpret as kidney mitochondrial dysfunction.
This is not a paradox once you understand the framework: urinary succinate is a phenotype indicator, not a simple good-or-bad number. In early diabetic injury, the kidneys leak more succinate. In advanced non-diabetic kidney disease, the kidneys lose the metabolic capacity to generate it. Your trend matters more than any single value, and how it moves should always be interpreted alongside kidney filtration and protein-in-urine tests.
In clear cell renal cell carcinoma, the most common form of kidney cancer, the change in urinary succinate before and after surgery was one of several urine metabolites that together predicted whether the cancer would come back. The model performed well in a small study, suggesting succinate may carry useful prognostic information when combined with other markers in this specific population.
In a small pilot study, urinary succinate was significantly higher in people with Parkinson's disease than in controls. Levels also correlated with motor symptom severity, though the direction of that correlation was complex. The researchers framed succinate as a possible marker of disease progression, likely reflecting both gut-derived metabolism and mitochondrial stress, two processes increasingly implicated in Parkinson's biology.
A small urine metabolomics study in women with polycystic ovary syndrome (PCOS) found markedly lower urinary succinate than in healthy controls, alongside changes in several other metabolites. The finding fits with growing evidence that PCOS involves shifts in energy metabolism, but the study is small and succinate alone is not a stand-alone diagnostic test for PCOS.
In a study of people with epithelial ovarian cancer, urinary succinate was part of a metabolite panel that shifted toward normal after surgical removal of the tumor. The pattern supports succinate's role as one piece of a broader cancer-related metabolic signature rather than a single tumor marker.
Urinary succinate is a research-grade marker without standardized reference ranges, and it sits in a metabolic pathway that responds to many short-term inputs, from what you ate yesterday to how hard you trained this week. A single value, in isolation, is hard to interpret confidently.
Your own trend is far more informative. Establishing a baseline and tracking how the number changes over months gives you something concrete to compare against, especially if you are making lifestyle changes or monitoring a kidney or metabolic condition. A practical cadence: baseline now, retest in 3 to 6 months if you are actively changing diet, exercise, or medications, then at least annually to watch for drift.
Because the science is still maturing, getting a baseline early gives you a head start. As reference ranges and clinical interpretations become more refined, you will have your own data to compare against, rather than starting from scratch.
Several factors can distort a single urine succinate reading. The most important ones to know:
Because urinary succinate is not a stand-alone diagnostic test, an out-of-pattern result is a prompt to investigate, not a verdict. Start by retesting under standardized conditions, ideally a morning sample with consistent diet and activity in the days prior.
If the trend persists, the next step depends on context. If you have type 2 diabetes or other diabetes risk factors and your succinate is trending high, pair the result with kidney filtration (eGFR) and urine protein testing to assess for early diabetic kidney involvement, and involve a nephrologist if those secondary markers are also off. If you have established kidney disease and succinate is trending low, that pattern fits with progression of mitochondrial dysfunction in the kidney and warrants closer kidney follow-up.
For most other readers, an isolated unusual result without other signs of kidney, metabolic, or neurologic disease is best treated as one data point in a larger picture. The most useful action is usually to retest over time and look at the trend in combination with a broader metabolic and kidney workup, rather than to chase a single number.
Succinic Acid is best interpreted alongside these tests.
Succinic Acid is included in these pre-built panels.